Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2003
09/18/2003US20030175868 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175867 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175866 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/18/2003US20030175865 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/18/2003US20030175864 Human FRP and fragments thereof including methods for using them
09/18/2003US20030175861 Monoterpene synthases from grand fir (abies grandis)
09/18/2003US20030175860 Seleno-cysteine containing protein zsel1
09/18/2003US20030175859 Fluorescent proteins
09/18/2003US20030175857 Of given sequence termed Con-218; constructs and recombinant host cells incorporating the genes; antibodies ; used as therapeutic target and to purify G-proteins
09/18/2003US20030175855 Human sdf-5 protein and compositions
09/18/2003US20030175854 System and method for gene expression in thermus strains
09/18/2003US20030175840 Kit which detects ligand associated with nuclear factor kappa beta receptor for treating toxic shock, sepsis, inflammation and graft vs host disease
09/18/2003US20030175830 Reagents and methods for the screening of compounds useful in the treatment of neurological diseases
09/18/2003US20030175829 DSP-4 dual-specificity phosphatase
09/18/2003US20030175826 Which have acrylic amide polymer immobilized thereto; heat shock proteins
09/18/2003US20030175825 Cytokine receptor zalpha11
09/18/2003US20030175823 Method of screening remedy for heart failures
09/18/2003US20030175822 Opiate, cannabinoid, and estrogen receptors
09/18/2003US20030175808 Novel protein and dna thereof
09/18/2003US20030175807 Chimeric GFP-aequorin as bioluminescent Ca+at the single cell level
09/18/2003US20030175805 Comprises winglesslint 8D (Wnt-8D) polypeptides for treating asthma, nervous system, psychological, alzheimer, cancer, cardiomyopathies, lung and kidney disorders; wound healing agents; tissue engineering
09/18/2003US20030175794 Compositions for isolating a cDNA encoding a membrane-bound protein
09/18/2003US20030175793 Comprises oligonucleotides for use in gene expression inhibition and treatment of cancer, multiple sclerosis and atherosclerosis
09/18/2003US20030175790 High throughput screening for detecting modulators of molecular interaction and cellular processes
09/18/2003US20030175786 Comprises nucleotide sequence coding enzymatic polypeptide for diagnosing, preventing and treatment of cell proliferative/differentiation and cancer disorders
09/18/2003US20030175785 Replication, detection and quantification of RNA sequences
09/18/2003US20030175783 Methods and means for monitoring and modulating gene silencing
09/18/2003US20030175779 Preparing solid support comprising immobilized biopolymers for detecting, measuring, separating and/or assaying DNA or proteins in a sample
09/18/2003US20030175776 Hybridization accelerator and accelerating method
09/18/2003US20030175775 Ligand for G-protein coupled receptor GPR43 and uses thereof
09/18/2003US20030175774 Single-tube, ready-to-use assay kits and methods using same
09/18/2003US20030175772 Microarray of nuclelotide sequences for use in gene expression inhibition; antisense therapy; antitumor agents
09/18/2003US20030175769 Reagents for improved PCR
09/18/2003US20030175767 Chemoreceptors in plant parasitic nematodes
09/18/2003US20030175766 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
09/18/2003US20030175765 Using oligonucleotide probes for detecting the presence of viral nucleotide sequences; medical, forensic, food, environmental diagnostics; plant protection; veterinary medicine
09/18/2003US20030175764 Monitoring interleukin allelic expression to detect occlusive, fragile plaque, restenosive and atherscerotic disorders
09/18/2003US20030175759 Using electrophoresis and restriction fragment length polymorphisms to identify preferential nucleotide sequences in data base
09/18/2003US20030175753 Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling
09/18/2003US20030175751 Having substituents such as steroids, reporter molecules/enzymes, non-aromatic lipophilic molecules, peptides, or proteins attached via linking groups; improved diagnosis
09/18/2003US20030175750 Identifying one or more of a plurality of sequences differing by one or more single-base changes; restriction fragment length polymorphisms
09/18/2003US20030175747 Microfluidic apparatus for detection, separation and classification multiple DNA sequences; restriction fragment length polymorphisms
09/18/2003US20030175746 Using oligonucleotide primers complimentary to virulence determinant genes (VDG) for classifying, identifying and diagnosing campylobacter infection
09/18/2003US20030175745 Peptides with growth inhibitory action
09/18/2003US20030175744 Replication primer sequences for identifying ligand-binding domains for detection of neuron odorants, toxic odors and which can be used to manipulate odor response in animals
09/18/2003US20030175741 PCP-administered (phencyclidine/angel dust) chronic animal models; drug screening
09/18/2003US20030175738 Rna polymerase mutants with increased thermostability
09/18/2003US20030175736 Classifying and characterizing prostate gland tissues via monitoring expression of tumor markers such as, hepsin, pim-1, ezh2 or alpha-methylacyl-coa racemase for diagnosing prostate/urogenital health
09/18/2003US20030175735 Recombinant adenylcyclase and use thereof for screening molecules with proteolytic activity
09/18/2003US20030175732 Chromosomal region containing quantitative trait loci associated with correlating preferential genotype and phenotype with corn digestibility and lignin biosynthesis
09/18/2003US20030175731 Hybrid immunomodulatory peptide and nucleotide sequences for treating allergies
09/18/2003US20030175730 Comprises nucleotide sequences coding ribozyme and splicing sequences for use as efficient tools in gene therapy and expression analysis
09/18/2003US20030175726 Design of artificial genes for use as controls in gene expression analysis systems
09/18/2003US20030175725 Mycobacterial diagnostics
09/18/2003US20030175724 Promoter libraries and their use in identifying promoters, transcription initiation sites and transcription factors
09/18/2003US20030175723 Methods and compositions for mutation analysis
09/18/2003US20030175719 Random array of micro-spheres for the analysis of nucleic acid using enzyme digestion
09/18/2003US20030175713 Method for diagnosis of inflammatory diseases using CALGRANULIN C
09/18/2003US20030175711 Comprises ordered and repetitive antigen or antigenic determinant array for developing vaccines for treatment of infectious diseases, allergies and cancer; microarrays
09/18/2003US20030175709 Method and system for depleting rRNA populations
09/18/2003US20030175708 Nucleic acids and proteins from cenarchaeum symbiosum
09/18/2003US20030175706 Using oligonuclelotide probes for rapid, automated detection of infectious pathogenic agents as well as wild type and mutant gene expression
09/18/2003US20030175703 RNA aptamers and methods for identifying the same
09/18/2003US20030175702 Electronic array for solid phase synthesis; kits
09/18/2003US20030175700 Comprises nucleotide sequences coding chlamydia antigen for serodiagnosis and traetment of infection; genetic vaccines
09/18/2003US20030175698 Retrovirus-specific oligonucleotides and a method for measuring retroviral titer using same
09/18/2003US20030175697 Comprises primers which hybridize conserved sequences; polymerase chain reactions; ribonucleases; mass spectrometry; drug screening
09/18/2003US20030175696 Comprises primers which hybridize conserved sequences; polymerase chain reactions; ribonucleases; mass spectrometry; drug screening
09/18/2003US20030175695 Method for rapid detection and identification of bioagents
09/18/2003US20030175692 Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis C virus protease
09/18/2003US20030175691 Method for isolating proteins or protein and nucleic acid associations, or particle and protein complexes, reagent and uses
09/18/2003US20030175688 Preparing replication competent viral vectors for treating cancer; genetic vaccines; gene therapy; antitumor agents
09/18/2003US20030175685 Using amino acid sequences to control apoptosis and prevent or treat cancer and viral infections
09/18/2003US20030175683 In vitro system for replication of RNA-dependent RNA polymerase (RDRP) viruses
09/18/2003US20030175680 Methods of treating and preventing bone loss
09/18/2003US20030175679 Detecting modulators of ubiquitin conjugating enzyme complex formation; drug screening
09/18/2003US20030175678 Monitoring transgenic plants for increased expression of catechin and terpenes
09/18/2003US20030175311 A protein encoded by DNA sequence, for protecting poultry; veterinary medicine
09/18/2003US20030175304 Recombinant dimeric envelope vaccine against flaviviral infection
09/18/2003US20030175303 Production method of recombinant rotavirus structural proteins and vaccine composition
09/18/2003US20030175301 Rotavirus pseudoviral particles and use thereof for vectorizing proteins of nucleic acids
09/18/2003US20030175297 Cancer vaccines
09/18/2003US20030175296 Chimaeric hepadnavirus core antigen proteins
09/18/2003US20030175293 Choline binding proteins for anti-pneumococcal vaccines
09/18/2003US20030175292 Compositions and methods for generating an immune response
09/18/2003US20030175291 Multiple and multivalent DNA vaccines in ovo
09/18/2003US20030175290 Molecular antigen array
09/18/2003US20030175289 TIE ligands
09/18/2003US20030175287 Fusion proteins comprising Pathogen Associated Molecular Patterns (PAMPs), immunostimulants and antigen or immunogens, administered to activate lymphocytes; immunology
09/18/2003US20030175280 Antagonists to chaperonin 10
09/18/2003US20030175276 Monoclonal antibodies used as antagonists vascular endothelial growth factors (VEGF); angiogenesis inhibitors; antitumor agents
09/18/2003US20030175274 Polynucleotides codes for antibodies having amino acid sequences selected from complementary determining regions of variable peptides or single chain fragments, used as anticarcinogenic agents
09/18/2003US20030175273 Monoclonal antibodies which preferentially bind to chemokine receptors, used for immunotherapy, as antiinflammatory, aniticarcinogenic agents and for prophylaxis of respiratory system disorders or antiallergens
09/18/2003US20030175269 Light and heavy chain peptides, used as antagonists of CD antigen or membrane proteins, for prophylaxis of autoimmune diseases
09/18/2003US20030175265 Chandra: a novel Th1-specific gene
09/18/2003US20030175257 Cartilage regeneration using chondrocyte and TGF-beta
09/18/2003US20030175252 Therapeutic compounds for ovarian cancer
09/18/2003US20030175246 Toxin-phage bacteriocide antibiotic and uses thereof
09/18/2003US20030175245 Replication deficient adenoviral TNF vector
09/18/2003US20030175244 Capsid-modified recombinant adenovirus and methods of use
1 ... 2420 2421 2422 2423 2424 2425 2426 2427 2428 2429 2430 2431 2432 2433 2434 2435 2436 2437 2438 2439 2440 ... 4023